Albachem Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue -12.60%
(FY 2020)
- Profit -19.52%
(FY 2020)
- Ebitda -160.69%
(FY 2020)
- Net Worth 11.63%
(FY 2020)
- Total Assets -22.38%
(FY 2020)
About Albachem Bioscience
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Rai and Vivek Kumar serve as directors at the Company.
- CIN/LLPIN
U24232MP2013PTC031743
- Company No.
031743
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2013
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Albachem Bioscience Private Limited offer?
Albachem Bioscience Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Laxatives, Common Disease Medicines, Pharmaceutical Capsules, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Antihistamines.
Who are the key members and board of directors at Albachem Bioscience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Rai  | Director | 08-Nov-2013 | Current |
| Vivek Kumar | Director | 12-Nov-2019 | Current |
Financial Performance of Albachem Bioscience.
Albachem Bioscience Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12.6% decrease. The company also saw a substantial fall in profitability, with a 19.52% decrease in profit. The company's net worth Soared by an impressive increase of 11.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Albachem Bioscience?
Unlock access to Albachem Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Freunde Hospitality Private LimitedActive 5 years 3 monthsJitendra Rai and Vivek Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Albachem Bioscience?
Unlock and access historical data on people associated with Albachem Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Albachem Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albachem Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
